Introducere. Cancerul pancreatic (CP), o problemă oncologică majoră cu evoluție severă şi pronostic sumbru, fiind diagnosticat în stadiile precoce poate beneficia de tratament chirurgical radical şi speranţe de viaţă mai mari. Scopul lucrării. Determinarea volumului tratamentului chirurgical radical şi paliativ în cancerul pancreatic. Material şi metode. Studiul retrospectiv din 181 de bolnavi cu CP cu aprecierea stadiului tumorii şi volumului tratamentului chirurgical, datele clinice, paraclinice de laborator şi instrumentale (USG, CT). Rezultate. Tratamentul chirurgical radical în CP a constituit 7,7% (14 cazuri) versus 92,3% (167 cazuri) – cu tratament chirurgical paliativ. Au fost efectuate 14 (7,7%) operaţii radicale – 11 rezecţii pancreatoduodenale, 3 hemirezecţii distale. Operaţiile paliative au constituit 92,3% (167 cazuri) dintre care 69 CEA (Colecistoenteroanastomoză) (40 combinate cu GEA (Gastroenteroanastomoză), 31 GEA, 17 CGA (Colecistogastroanastomoză), 7 drenări transhepatice, 5 stentări endoscopice şi 39 laparotomii explorative. Concluzii. Ponderea tratamentului chirurgical paliativ (92,3%) versus cel radical (7,7%) cu raport 12,1/1 demonstreazăcă diagnosticul precoce în stadiile operabile este dificil, argumentat prin evoluţia asimptomatică. Indicaţiile către tratamentul chirurgical radical au servit: tumora strict localizată în limitele pancreasului fără invazie vasculară, lipsa metastazelor la distanţă şi operabilitatea funcţională a bolnavului.    

Introduction. Pancreatic Cancer (CP), a major oncological problem with severe and pronounced prognosis when being early diagnosed, can benefit with radical surgery and higher life expectancy. Objective of the study. Determining the volume of radical and palliative surgical treatment in pancreatic cancer. Material and methods. The retrospective study of 181 patients with CP with appreciation of the stage of the tumor and the volume of surgical treatment; clinical, laboratory and instrumental data (ULTRASOUND, CT). Results. The radical surgical treatment in CP was performed in 7.7% (14 cases) versus 92.3% (167 cases) – with palliative surgical treatment. Radical interventions 14 (7.7%) were performed: 11 pancreatoduodenal resections and 3 distal hemirections. Palliative operations amounted up to 92.3% (167 cases) of which 69 cases of CEA (Colecistoenteroanastomosis) (40 combined with the GEA (Gastroenteroanastomosis), 31 cases of GEA, 17 cases of CGA (Colecistogastroanastomosis), 7 – drainage transhepatice, 5 – stenting endoscopic and 39 – laparotomies explorative. Conclusions. The percentage of surgical palliative treatment (92.3%) versus the radical (7.7%) in ratio of 12.1/1 which demonstrates that early diagnosis in operable stages is difficult, argued by asymptomatic progression. Indications for radical surgical treatment were: a tumor located strictly in the pancreas without invading large vessels, lack of metastasis at a distance and functional operability of the patient.